Development of a recombinant adenovirus-vectored vaccine against both infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss)

Fish Shellfish Immunol. 2023 Jan:132:108457. doi: 10.1016/j.fsi.2022.108457. Epub 2022 Nov 29.

Abstract

Infectious hematopoietic necrosis virus (IHNV) and infectious pancreatic necrosis virus (IPNV) are typical pathogens of rainbow trout Oncorhynchus mykiss, and the concurrent infection of the two viruses is very common among modern trout hatcheries, which has caused huge economic losses to the rainbow trout farming industry. To prevent and control the spread of IHNV and IPNV in juvenile trout simultaneously, in this study a bivalent recombinant adenovirus vaccine with IHNV Glycoprotein (G) and IPNV VP2 genes was developed. After immunizing juvenile trout with this bivalent vaccine via the immersion route, the expression levels of IHNV G and IPNV VP2 and the representative immune genes in vaccinated and control rainbow trout were tested to evaluate the correlation of immune responses with the expression of viral genes. The neutralizing antibody level induced by this bivalent vaccine as well as the protection efficacy of the vaccine against IHNV and IPNV was also evaluated. The results showed that IHNV G and IPNV VP2 were successfully expressed in juvenile trout, and all the innate and adaptive immune genes were up-regulated. This indicated that the level of the innate and adaptive immune responses were significantly increased, which might be induced by the high expression of the two viral proteins. Compared with the controls, high levels of neutralizing antibodies against IHNV and IPNV were induced in the vaccinated trout. Besides, the bivalent recombinant adenovirus vaccine showed high protection rate against IHNV, with the relative percent survival (RPS) of 81.25%, as well as against IPNV, with the RPS of 78.95%. Taken together, our findings clearly demonstrated that replication-defective adenovirus can be developed as a qualified vector for fish vaccines and IHNV G and IPNV VP2 were two suitable antigenic genes that could induce effective immune protection against these two pathogens. This study provided new insights into developing bivalent vectored vaccines and controlling the spread of IHNV and IPNV simultaneously in juvenile trout.

Keywords: Bivalent vaccine; IHNV; IPNV; Immersion immunization; Immune response; Recombinant adenovirus.

MeSH terms

  • Adenoviridae / genetics
  • Adenovirus Vaccines*
  • Animals
  • Birnaviridae Infections* / prevention & control
  • Birnaviridae Infections* / veterinary
  • Fish Diseases*
  • Infectious hematopoietic necrosis virus* / physiology
  • Infectious pancreatic necrosis virus* / physiology
  • Oncorhynchus mykiss*
  • Rhabdoviridae Infections* / prevention & control
  • Rhabdoviridae Infections* / veterinary
  • Vaccines, Synthetic
  • Viral Vaccines*

Substances

  • Adenovirus Vaccines
  • Viral Vaccines
  • Vaccines, Synthetic